Lipid and lipoprotein levels remain stable in acute ischemic stroke: The Northern Manhattan Stroke Study

D. E. Kargman, C. Tuck, Lars Berglund, I. F. Lin, R. S. Mukherjee, E. V. Thompson, J. Jones, B. Boden-Albala, M. C. Paik, R. L. Sacco

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Serum lipoproteins including lipoprotein(a), Lp(a), are emerging as possible biological markers for cerebrovascular disease. Existing data on Lp(a) and serum lipids levels following acute ischemic stroke (AIS) are however equivocal. To determine whether serum Lp(a) and other lipid levels obtained within 24 h of acute ischemic stroke onset changed over the ensuing 4 weeks and whether these levels are related to an acute phase response, acquired nutritional deficiency, and neurovascular data, we conducted repeated measurement analyses among 19 subjects (mean age 65.0 ± 12.1 years; 32% women) presenting with AIS (evaluated within 9.7 ± 12.7 h). Eleven of the subjects had a moderate-to-severe stroke, defined by NIH stroke severity scale, and seven patients had a large cerebral infarction. Seven serial measurements of Lp(a), total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and other lipoproteins, major acute phase reactants and albumin levels were collected for each subject over 4 weeks. The mean initial levels, (mg/dl), of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, Lp(a), apolipoproteins A-I and B were: 22 ±57.6, 154 ± 56.0, 40 ± 10.4, 181 ± 93.7, 52 ± 28.6, 130 ± 24.6, and 141 ± 46.1, respectively. There were no significant changes in mean serum lipid, apolipoprotein or Lp(a) levels over the 4-week study period, analyzed by a random effects model to test for time trend. In addition, there were no significant changes in established acute phase or nutritional markers (C-reactive protein, alpha 1-glycoprotein, haptoglobin or serum albumin). Our findings suggest that serum lipid, apolipoprotein and Lp(a) levels remain stable following AIS, consistent with the absence of acute phase response or nutritional deficiency.

Original languageEnglish (US)
Pages (from-to)391-399
Number of pages9
JournalAtherosclerosis
Volume139
Issue number2
DOIs
StatePublished - Aug 4 1998
Externally publishedYes

Fingerprint

Lipoproteins
Stroke
Lipids
Apoprotein(a)
Serum
Acute-Phase Reaction
Malnutrition
LDL Cholesterol
HDL Cholesterol
Cholesterol
Cerebrovascular Disorders
Lipoprotein(a)
Haptoglobins
Acute-Phase Proteins
Apolipoprotein A-I
Cerebral Infarction
Apolipoproteins B
Serum Albumin
C-Reactive Protein
Albumins

Keywords

  • Acute phase reactants
  • Lipids
  • Lipoprotein(a)
  • Stroke

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Kargman, D. E., Tuck, C., Berglund, L., Lin, I. F., Mukherjee, R. S., Thompson, E. V., ... Sacco, R. L. (1998). Lipid and lipoprotein levels remain stable in acute ischemic stroke: The Northern Manhattan Stroke Study. Atherosclerosis, 139(2), 391-399. https://doi.org/10.1016/S0021-9150(98)00085-9

Lipid and lipoprotein levels remain stable in acute ischemic stroke : The Northern Manhattan Stroke Study. / Kargman, D. E.; Tuck, C.; Berglund, Lars; Lin, I. F.; Mukherjee, R. S.; Thompson, E. V.; Jones, J.; Boden-Albala, B.; Paik, M. C.; Sacco, R. L.

In: Atherosclerosis, Vol. 139, No. 2, 04.08.1998, p. 391-399.

Research output: Contribution to journalArticle

Kargman, DE, Tuck, C, Berglund, L, Lin, IF, Mukherjee, RS, Thompson, EV, Jones, J, Boden-Albala, B, Paik, MC & Sacco, RL 1998, 'Lipid and lipoprotein levels remain stable in acute ischemic stroke: The Northern Manhattan Stroke Study', Atherosclerosis, vol. 139, no. 2, pp. 391-399. https://doi.org/10.1016/S0021-9150(98)00085-9
Kargman, D. E. ; Tuck, C. ; Berglund, Lars ; Lin, I. F. ; Mukherjee, R. S. ; Thompson, E. V. ; Jones, J. ; Boden-Albala, B. ; Paik, M. C. ; Sacco, R. L. / Lipid and lipoprotein levels remain stable in acute ischemic stroke : The Northern Manhattan Stroke Study. In: Atherosclerosis. 1998 ; Vol. 139, No. 2. pp. 391-399.
@article{6bef7885ce1b4b2dbd1cd77b4498c4d1,
title = "Lipid and lipoprotein levels remain stable in acute ischemic stroke: The Northern Manhattan Stroke Study",
abstract = "Serum lipoproteins including lipoprotein(a), Lp(a), are emerging as possible biological markers for cerebrovascular disease. Existing data on Lp(a) and serum lipids levels following acute ischemic stroke (AIS) are however equivocal. To determine whether serum Lp(a) and other lipid levels obtained within 24 h of acute ischemic stroke onset changed over the ensuing 4 weeks and whether these levels are related to an acute phase response, acquired nutritional deficiency, and neurovascular data, we conducted repeated measurement analyses among 19 subjects (mean age 65.0 ± 12.1 years; 32{\%} women) presenting with AIS (evaluated within 9.7 ± 12.7 h). Eleven of the subjects had a moderate-to-severe stroke, defined by NIH stroke severity scale, and seven patients had a large cerebral infarction. Seven serial measurements of Lp(a), total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and other lipoproteins, major acute phase reactants and albumin levels were collected for each subject over 4 weeks. The mean initial levels, (mg/dl), of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, Lp(a), apolipoproteins A-I and B were: 22 ±57.6, 154 ± 56.0, 40 ± 10.4, 181 ± 93.7, 52 ± 28.6, 130 ± 24.6, and 141 ± 46.1, respectively. There were no significant changes in mean serum lipid, apolipoprotein or Lp(a) levels over the 4-week study period, analyzed by a random effects model to test for time trend. In addition, there were no significant changes in established acute phase or nutritional markers (C-reactive protein, alpha 1-glycoprotein, haptoglobin or serum albumin). Our findings suggest that serum lipid, apolipoprotein and Lp(a) levels remain stable following AIS, consistent with the absence of acute phase response or nutritional deficiency.",
keywords = "Acute phase reactants, Lipids, Lipoprotein(a), Stroke",
author = "Kargman, {D. E.} and C. Tuck and Lars Berglund and Lin, {I. F.} and Mukherjee, {R. S.} and Thompson, {E. V.} and J. Jones and B. Boden-Albala and Paik, {M. C.} and Sacco, {R. L.}",
year = "1998",
month = "8",
day = "4",
doi = "10.1016/S0021-9150(98)00085-9",
language = "English (US)",
volume = "139",
pages = "391--399",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Lipid and lipoprotein levels remain stable in acute ischemic stroke

T2 - The Northern Manhattan Stroke Study

AU - Kargman, D. E.

AU - Tuck, C.

AU - Berglund, Lars

AU - Lin, I. F.

AU - Mukherjee, R. S.

AU - Thompson, E. V.

AU - Jones, J.

AU - Boden-Albala, B.

AU - Paik, M. C.

AU - Sacco, R. L.

PY - 1998/8/4

Y1 - 1998/8/4

N2 - Serum lipoproteins including lipoprotein(a), Lp(a), are emerging as possible biological markers for cerebrovascular disease. Existing data on Lp(a) and serum lipids levels following acute ischemic stroke (AIS) are however equivocal. To determine whether serum Lp(a) and other lipid levels obtained within 24 h of acute ischemic stroke onset changed over the ensuing 4 weeks and whether these levels are related to an acute phase response, acquired nutritional deficiency, and neurovascular data, we conducted repeated measurement analyses among 19 subjects (mean age 65.0 ± 12.1 years; 32% women) presenting with AIS (evaluated within 9.7 ± 12.7 h). Eleven of the subjects had a moderate-to-severe stroke, defined by NIH stroke severity scale, and seven patients had a large cerebral infarction. Seven serial measurements of Lp(a), total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and other lipoproteins, major acute phase reactants and albumin levels were collected for each subject over 4 weeks. The mean initial levels, (mg/dl), of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, Lp(a), apolipoproteins A-I and B were: 22 ±57.6, 154 ± 56.0, 40 ± 10.4, 181 ± 93.7, 52 ± 28.6, 130 ± 24.6, and 141 ± 46.1, respectively. There were no significant changes in mean serum lipid, apolipoprotein or Lp(a) levels over the 4-week study period, analyzed by a random effects model to test for time trend. In addition, there were no significant changes in established acute phase or nutritional markers (C-reactive protein, alpha 1-glycoprotein, haptoglobin or serum albumin). Our findings suggest that serum lipid, apolipoprotein and Lp(a) levels remain stable following AIS, consistent with the absence of acute phase response or nutritional deficiency.

AB - Serum lipoproteins including lipoprotein(a), Lp(a), are emerging as possible biological markers for cerebrovascular disease. Existing data on Lp(a) and serum lipids levels following acute ischemic stroke (AIS) are however equivocal. To determine whether serum Lp(a) and other lipid levels obtained within 24 h of acute ischemic stroke onset changed over the ensuing 4 weeks and whether these levels are related to an acute phase response, acquired nutritional deficiency, and neurovascular data, we conducted repeated measurement analyses among 19 subjects (mean age 65.0 ± 12.1 years; 32% women) presenting with AIS (evaluated within 9.7 ± 12.7 h). Eleven of the subjects had a moderate-to-severe stroke, defined by NIH stroke severity scale, and seven patients had a large cerebral infarction. Seven serial measurements of Lp(a), total cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, and other lipoproteins, major acute phase reactants and albumin levels were collected for each subject over 4 weeks. The mean initial levels, (mg/dl), of total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, Lp(a), apolipoproteins A-I and B were: 22 ±57.6, 154 ± 56.0, 40 ± 10.4, 181 ± 93.7, 52 ± 28.6, 130 ± 24.6, and 141 ± 46.1, respectively. There were no significant changes in mean serum lipid, apolipoprotein or Lp(a) levels over the 4-week study period, analyzed by a random effects model to test for time trend. In addition, there were no significant changes in established acute phase or nutritional markers (C-reactive protein, alpha 1-glycoprotein, haptoglobin or serum albumin). Our findings suggest that serum lipid, apolipoprotein and Lp(a) levels remain stable following AIS, consistent with the absence of acute phase response or nutritional deficiency.

KW - Acute phase reactants

KW - Lipids

KW - Lipoprotein(a)

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=0031859239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031859239&partnerID=8YFLogxK

U2 - 10.1016/S0021-9150(98)00085-9

DO - 10.1016/S0021-9150(98)00085-9

M3 - Article

C2 - 9712347

AN - SCOPUS:0031859239

VL - 139

SP - 391

EP - 399

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -